The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer (I)
 
Consulting or Advisory Role - United Therapeutics
Speakers' Bureau - United Therapeutics
Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321).
 
Ira J. Dunkel
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst)
 
Mark D. Krailo
No Relationships to Disclose
 
Guillermo L. Chantada
No Relationships to Disclose
 
Anuradha Banerjee
No Relationships to Disclose
 
Sherif Abouelnaga
No Relationships to Disclose
 
Jeffrey Buchsbaum
No Relationships to Disclose
 
Thomas E. Merchant
Travel, Accommodations, Expenses - IBA
 
Meaghan Granger
No Relationships to Disclose
 
Rima Fuad Jubran
No Relationships to Disclose
 
Michael Kellick
No Relationships to Disclose
 
Joanna Weinstein
No Relationships to Disclose
 
David H. Abramson
No Relationships to Disclose
 
Carlos Rodriguez-Galindo
Honoraria - Novimmune
 
Murali M. Chintagumpala
No Relationships to Disclose